View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

PepsiCo, Inc. - March 2024 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

 PRESS RELEASE

Virtu Financial Congratulates Michelle Hosea, Recipient of the Rising ...

Virtu Financial Congratulates Michelle Hosea, Recipient of the Rising Star Award at Women in Finance Asia Awards NEW YORK, May 17, 2024 (GLOBE NEWSWIRE) -- Virtu Financial, Inc. (Nasdaq:VIRT), a leading provider of global, multi-asset financial services that delivers liquidity and innovative, transparent products across the complete investment cycle to the global markets, is pleased to congratulate Michelle Hosea, Quantitative Strategist, on her Women in Finance Asia 2024 Rising Star Award. In Michelle’s three years at Virtu, she has quickly taken a leadership role on the quantitative ...

Martin Fan ... (+4)
  • Martin Fan
  • Ritika Das
  • Robert Driscoll
  • Sam Ravina
 PRESS RELEASE

Amalgamated Financial Corp. Commits Additional $85 Million to Finance ...

Amalgamated Financial Corp. Commits Additional $85 Million to Finance R-PACE Assessments NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- Amalgamated Financial Corp. (“Amalgamated” or the “Company”) (Nasdaq: AMAL) announced that the Company has extended its commitment to invest in Residential Property Assessed Clean Energy (“R-PACE”) assessments through its ongoing partnership with Home Run Finance (“HRF”). Amalgamated’s commitment provides an additional $85 million of capital to fund R-PACE assessments originated by HRF. Priscilla Sims Brown, President and Chief Executive Officer, commented, ...

 PRESS RELEASE

Cullinan Therapeutics Provides Corporate Update and Reports First Quar...

Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results Combination and monotherapy solid tumor dose escalation data for CLN-619 to be presented in a poster session at ASCO 2024 Annual Meeting CLN-978 development to focus exclusively on autoimmune diseases, starting with systemic lupus erythematosus (SLE) as the first indication Cash and investments of $434.8 million as of March 31, 2024, plus gross proceeds of $280 million from April private placement extends cash runway into 2028 Company appoints David Meek to its Board of Directors CAMBRIDGE, ...

Integer Holdings Corp: 1 director

A director at Integer Holdings Corp sold 8,712 shares at 113.836USD and the significance rating of the trade was 82/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...

PepsiCo Inc: 1 director

A director at PepsiCo Inc sold 6,628 shares at 179.863USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...

 PRESS RELEASE

Rani Therapeutics to Participate in May Investor Conferences

Rani Therapeutics to Participate in May Investor Conferences SAN JOSE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that the Company will participate in two upcoming investor conferences in May 2024. These conferences include: H.C. Wainwright 2nd Annual BioConnect Investor ConferenceLocation: The Nasdaq Headquarters, New York CityDate: Monday, May 20th at 2:30pm E.TFormat: Fireside Chat and 1x1 Investor ...

Lifeway Foods Inc: 1 director

A director at Lifeway Foods Inc sold 15,000 shares at 27.017USD and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

 PRESS RELEASE

Orion Group Holdings Announces Significant Contract Award for Port Eve...

Orion Group Holdings Announces Significant Contract Award for Port Everglades Bulkhead Replacement Project HOUSTON, May 09, 2024 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (the “Company”), a leading specialty construction company, today announced a significant contract award valued at nearly $80 million for its Marine construction business. The contract was awarded by Port Everglades Seaport Engineering & Construction Division through Moss Construction as Managing General Contractor for the Port Everglades Bulkhead Replacement Project – Group 1, a pivotal infrastructure up...

 PRESS RELEASE

ALX Oncology Reports First Quarter 2024 Financial Results and Provides...

ALX Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update SOUTH SAN FRANCISCO, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that block the CD47 immune checkpoint pathway, today reported financial results for the first quarter ended March 31, 2024, and provided a corporate update. “We entered the quarter with a great deal of momentum having achieved a key validating development milestone for our platform asset evorpacept in Q4 2023 by repo...

Jonathan Chaplin
  • Jonathan Chaplin

SATS: model update

This note covers updates to the model following consolidated EchoStar results. We increased service revenue and EBITDA. Our free cash flow is up very modestly. The company has five to seven months to raise capital. We updated our valuation to $95 / share. We will have another update out once we get the Dish, DBS & Hughes 10-Qs.

 PRESS RELEASE

Rani Therapeutics to Present Clinical and Preclinical Data on Oral Del...

Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024 SAN JOSE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it will present clinical and preclinical and data on the RaniPill® capsule, the company’s oral delivery platform, at Digestive Disease Week® (DDW) taking place both virtually and in-pers...

Jonathan Chaplin
  • Jonathan Chaplin

EchoStar: Quick thoughts following the call

In this brief note, we cover: 1) securitizable spectrum value; 2) when cash runs out; 3) the implications of the DBS lawsuit for raising new capital; 4) operating improvements in prepaid wireless; 4) progress on cost savings; 5) preliminary thoughts on a new strategy in postpaid wireless.

Moody's Ratings assigns Baa2 rating to Hasbro's new senior unsecured n...

Moody's Ratings (Moody's) today assigned a Baa2 rating to Hasbro, Inc.'s ("Hasbro") new senior unsecured notes.  All other ratings, including the Baa2 senior unsecured and Prime-2 commercial paper ratings remain unchanged. The rating outlook is negative. The company plans to issue Benchmark of 10-...

Jonathan Chaplin
  • Jonathan Chaplin

SATS 1Q24 Quick Take: Operating trends fine; focus will be on capital ...

Operating results were generally a bit better than expected. The Company appears to be doing what it can to preserve cash. The cash burn was $100MM higher than we expected and $200MM higher than consensus expected. We estimate that the Company has enough cash to get through the next two quarters, but barely.

Heritage Insurance Holdings Inc: 3 directors

A director at Heritage Insurance Holdings Inc bought 10,000 shares at 8.190USD and the significance rating of the trade was 36/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch